Daily Soup

Hemispherx Biopharma Inc. (AMEX: HEB)

Hemispherx Biopharma Inc. (HEB) is a biopharmaceutical company engaged in the clinical development, manufacture, marketing and distribution of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. The Company’s products include Ampligen and Alferon N and Injection. Ampligen includes application as a treatment for Chronic Fatigue Syndrome (CFS) and as a vaccine enhancer (adjuvant) for both therapeutic and preventative vaccine development. Alferon N is an indicator for refractory or recurring genital warts. Alferon LDO (Low Dose Oral) is an application under early stage development targeting influenza and viral diseases. Ampligen is an experimental drug undergoing clinical development for the treatment of CFS. continue

Wave Systems Corp. (NASDAQ: WAVX)

Wave Systems Corp. (WAVX) develops, produces and markets products for hardware-based digital security, including security applications and services that are complementary to and work with the specifications of the Trusted Computing Group (TCG), an industry standards organization comprised of computer and device manufacturers, software vendors and other computing products manufacturers. Specifications developed by the TCG are designed to address a range of digital security issues. These issues include identity protection, data security, digital signatures, electronic transaction integrity, platform trustworthiness, network security and regulatory compliance. WAVX serves chip original equipment manufacturers (OEMs), PC OEMs, enterprise customers and systems integrators. The Company was formerly known as Cryptologics International Inc. and changed its name to Wave Systems Corp. in January 1993. continue

Hologic Inc. (NASDAQ: HOLX)

Hologic Inc. (HOLX) is a developer, manufacturer and supplier of medical imaging systems and diagnostic and surgical products focused on the healthcare needs of women. It operates in four segments: Breast Health, Diagnostics, GYN Surgical and Skeletal Health. The Company had developed a breast imaging platform, Dimensions, which utilizes a technology, tomosynthesis, to produce three dimensional (3D) images, as well as conventional two dimensional (2D) full field digital mammography (FFDM) images. On August 27, 2009, it received the U.S. Food & Drug Administration (FDA) clearance for its MammoSite ML radiation therapy system, a multi-lumen device. In July 2009, it received FDA approval of the Adiana System. Hologic Inc. sells its products through a combination of direct sales and service force, and a network of independent distributors and sales representatives primarily in the United States, Europe and Asia. continue

Sun Microsystems Inc. (NASDAQ: JAVA)

Sun Microsystems Inc. (JAVA) provides network computing infrastructure solutions. The Company offers core brands, including the Java technology platform, the Solaris Operating System, the MySQL database management system, Sun StorageTek storage solutions and the UltraSPARC processor. Its network computing platforms are used by search, social networking, entertainment, financial services, manufacturing, healthcare, retail, news, energy and engineering companies. The Company operates in two segments: Server Products and Storage Products. Server Products comprised of Support Services (Support Services and Managed Services), and Professional and Educational Services. In January 2009, the Company acquired Q-layer, a cloud computing company that automates the deployment and management of both public and private clouds. It has strategic alliances and partnerships with Advanced Micro Devices Inc.; Fujitsu; Intel Corp.; and Hitachi Data Systems. continue

Genta Inc. (OTCBB: GETA)

Genta Inc. (GETA) is a biopharmaceutical company engaged in pharmaceutical (drug) research and development. The Company focuses on the identification, development and commercialization of drugs for the treatment of cancer and related diseases. GETA’s research portfolio consists of two major programs: Deoxyribonucleic Acid (DNA)/Ribonucleic Acid (RNA) Medicines and Small Molecules. The DNA/RNA Medicines program includes drugs that are based on using modifications of either DNA or RNA as drugs that can be used to treat disease. This program includes technologies, such as antisense, decoys and small interfering or micro RNAs. GETA’s drug from this program is an investigational antisense compound known as Genasense (oblimersen sodium injection). The Small Molecules program includes drugs, such as Ganite and investigational compounds tesetaxel and G4544. continue

BioElectronics Corp. (OTCPK: BIEL)

BioElectronics Corp. (BIEL) designs, develops and markets a variety of drug-free, anti-inflammatory patches for a range of medical indications. The Company’s patch products, which are marketed under the name ActiPatch Therapy, deliver pulsed electromagnetic field therapy, an anti-inflammatory and pain relief therapy. The ActiPatch Therapy products combine a miniaturized microchip, power source and antenna in a soft, flexible outer envelope. When applied to the body, these devices deliver a pulsed radio frequency signal into the body on a 27-megahertz (MHz) frequency wave that induces a low frequency electromagnetic field to damaged cell tissue. The Company markets its products in the United States, Canada and Europe. BIEL sells its products to wholesale distributors, as well as directly to hospitals and clinics. continue

Array BioPharma Inc. (NASDAQ: ARRY)

Array BioPharma Inc. (ARRY) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, inflammatory and metabolic diseases. In addition, pharmaceutical and biotechnology companies collaborate with the Company to discover and develop drug candidates across a range of therapeutic areas. The Company has seven wholly owned programs in its development pipeline: ARRY-403, a glucokinase activator for Type 2 diabetes; ARRY-162, a MEK inhibitor for rheumatoid arthritis and cancer; ARRY-380, an ErbB-2 inhibitor for breast cancer; ARRY-520, a KSP inhibitor for acute myeloid leukemia and multiple myeloma; ARRY-614, a p38/Tie 2 dual inhibitor for myelodysplastic syndrome; ARRY-543, an ErbB family (ErbB-2 / EGFR) inhibitor for solid tumors, and ARRY-797, a p38 inhibitor for subacute pain and cancer supportive care indications. continue

Melco Crown Entertainment Ltd. (NASDAQ: MPEL)

Melco Crown Entertainment Limited (MPEL), formerly Melco PBL Entertainment (Macau) Limited, is a developer, owner and, through its subsidiary Melco Crown Gaming, operator of casino gaming and entertainment resort facilities focused on the Macau market. Melco Crown Gaming is one of the six companies licensed, through concessions or sub-concessions, to operate casinos in Macau. The Company owns and operates Crown Macau resort that features a casino area of approximately 183,000 square feet with approximately 255 gaming tables and 95 gaming machines, as well as hotel rooms, fine dining and casual restaurants, recreation and leisure facilities, and meeting facilities; Mocha Clubs, which provide single-player machines with various games, including progressive jackpots; and multi-player games where players on linked machines play against each other in electronic roulette, baccarat, and sicbo. As of March 9, 2009, the company operated eight Mocha Clubs in Macau with a total of approximately 1,345 gaming machines. In addition, it owns and operates Taipa Square Casino with approximately 18,300 sq. ft. of gaming space and features approximately 31 gaming tables servicing rolling chip and mass market patrons. Further, MPEL is developing City of Dreams project, an integrated urban entertainment resort, combining casino with hotel offerings, entertainment venues, a performance theatre, retail, food and beverage outlets. continue

JA Solar Holdings Company Limited (NASDAQ: JASO)

JA Solar Holdings Company Limited (JASO) engages in the manufacturing, distribution and marketing of photovoltaic solar cells (PV). The Company’s customer base includes companies that assemble and integrate the Company’s PV cells into modules and systems designed to convert light energy into electricity. Founded in 2005, the Company is headquartered in Shanghai, China.

continue

Century Aluminum Co. (NASDAQ: CENX)

Century Aluminum Co. (CENX) is a holding company engaged in producing aluminum. The Company’s principal subsidiaries are Century Aluminum of West Virginia Inc., Berkeley Aluminum Inc., Century Kentucky Inc. and Nordural ehf. Century of West Virginia operates a primary aluminum reduction facility in Ravenswood, West Virginia. Berkeley holds a 49.7% interest in a partnership, which operates a primary aluminum reduction facility in Mt. Holly, South Carolina, and a 49.7% undivided interest in the property, plant and equipment comprising Mt. Holly. The remaining interest in the partnership and the remaining undivided interest in Mt. Holly are owned by Alumax of South Carolina Inc., a subsidiary of Alcoa (ASC). It also holds 50% joint-venture interests in the Gramercy alumina refinery, located in Gramercy, Louisiana, and a related bauxite mining operation in Jamaica. continue

Jazz Pharmaceuticals Inc. (NASDAQ: JAZZ)

Jazz Pharmaceuticals Inc. (JAZZ) is a specialty pharmaceutical company focused on developing and commercializing products to meet unmet medical needs in neurology and psychiatry. The marketed products and late-stage product candidate of the Company include Xyrem (sodium oxybate) oral solution, Luvox CR (fluvoxamine maleate) extended-release capsules and JZP-6 (sodium oxybate). The other product candidates in clinical development are JZP-8 (intranasal clonazepam), being developed for the treatment of recurrent acute repetitive seizures in epilepsy patients who continue to have seizures while on stable anti-epileptic regimens, JZP-4 (sodium and calcium channel antagonist), being developed for the treatment of epilepsy and bipolar disorder, and JZP-7 (ropinirole gel), being developed for the treatment of restless legs syndrome. continue

QuadraMed Corp. (NASDAQ: QDHC)

QuadraMed Corp. (QDHC) provides healthcare information technology (HIT) to hospitals and other healthcare organizations. Its solutions are used by organizations, such as hospitals, which includes community hospitals, academic hospitals, local and regional delivery networks, hospital-based clinics, and governmental agencies, including the 147 Veteran’s Administration hospitals (VA). QDHC’s solutions include QuadraMed Care Management Solutions (QCPR), QuadraMed Patient Revenue Management Solutions, QuadraMed Health Information Management Solutions (Quantim HIM), QuadraMed Access and Identity Management Solutions, and Governmental Solutions. continue

La Jolla Pharmaceuticals Co. (NASDAQ: LJPC)(D*)

* Financial status indicator is deficient: Issuer failed to meet NASDAQ continued listing requirements.

La Jolla Pharmaceutical Co. (LJPC) is a biopharmaceutical company focused on the development and testing of Riquent as a treatment for lupus nephritis, an antibody-mediated disease caused by abnormal B cell production of antibodies that attack healthy tissues. The Company’s wholly owned subsidiary is La Jolla Ltd. continue

Infinity Energy Resources Inc. (OTC PK: IFNY)

Infinity Energy Resources Inc. (IFNY) is an independent energy company engaged in the acquisition, exploration, development and production of natural gas and oil in the United States through its wholly owned subsidiaries, Infinity Oil and Gas of Texas Inc. (Infinity-Texas) and Infinity Oil & Gas of Wyoming Inc. (Infinity-Wyoming). Its operations are focused primarily in the Fort Worth Basin of Texas and the Greater Green River and Sand Wash Basins in the Rocky Mountain region. Infinity is also pursuing oil and gas exploration opportunities offshore Nicaragua in the Caribbean Sea. Infinity-Texas is engaged in the acquisition, exploration, development and production of natural gas in the Fort Worth Basin of north central Texas. Infinity-Wyoming is engaged in the acquisition, exploration, development and production of natural gas, condensate and crude oil in the Rocky Mountain region in Wyoming and Colorado. continue

Sigma Designs Inc. (NASDAQ: SIGM)

Sigma Designs Inc. (SIGM) is a fabless provider of integrated system-on-chip (SoC), solutions that are used to deliver multimedia entertainment throughout the home. The Company offers four distinct technologies that the Company markets as separate product lines: media processors, VXP video image processing, Ultra-wideband devices and Z-wave devices. Each of these technologies also contributes to its fully integrated SoC offerings. Its SoC solutions combine its semiconductors and software and are a component of multiple high-growth, consumer applications that process digital video and audio content, including Internet protocol television (IPTV), connected media player, high definition televisions (HDTVs), and portable media players. Its media processors provide high definition digital video decoding for multiple compression standards, graphics acceleration, audio decoding, a central processing unit (CPU) and display control. In November 2009, it acquired CopperGate Communications Ltd. continue

Keryx Biopharmaceuticals Inc. (NASDAQ: KERX)

Keryx Biopharmaceuticals Inc. (KERX) is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of life-threatening including renal disease and cancer. The Company is developing Zerenex (ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Zerenex is in phase II clinical development for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end stage renal disease (ESRD). KERX is developing KRX-0401 (perifosine), oral anti-cancer agent that modulates Akt, a protein in the body associated with tumor survival and growth. KRX-0401 is in phase II clinical development for multiple tumor types. KERX has strategic alliances with AEterna Zentaris Inc., Panion & BF Biotech Inc., Japan Tobacco Inc. and Torii Pharmaceutical Co. Ltd. for the manufacture and commercialization of its products. continue

Somaxon Pharmaceuticals Inc. (NASDAQ: SOMX)

Somaxon Pharmaceuticals Inc. (SOMX) is a specialty pharmaceutical company focused on the in-licensing and development of product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area. The Company is focused on the development of Silenor. SOMX completed its new drug application (NDA) for Silenor and submitted it to the United States Food and Drug Administration (FDA) on January 31, 2008. continue

ADC Telecommunications Inc. (NASDAQ: ADCT)

ADC Telecommunications Inc. (Nasdaq: ADCT) provides global network infrastructure products and services that enable the profitable delivery of high-speed Internet, video, data and voice services to residential, business and mobile subscribers worldwide.

The need for ubiquitous access, scalable bandwidth and robust, reliable connectivity is no different for a carrier, cable company or enterprise. All depend on ADCT’s network infrastructure expertise to help them design and deploy broadband networks, wired and wireless, that can deliver reliable broadband services over any device anytime, anywhere. continue

Red Branch Technologies (OTC PK: RBTI)

Red Branch Technologies (RBTI) provides sustainable-energy-powered solutions meeting commercial, industrial, municipal and federal requirements for site security, materials control, emergency communications, water purification and similar on-site applications. The Company simultaneously manages multiple renewable energy sources, and offers security products for military and law enforcement applications where cost/performance represents a critical selection factor. The application areas include Explosive Ordinance Disposal (EOD) robots, vehicular inspection and Unmanned Aerial Vehicles (UAVs). continue

BizAuction Inc. (OTC PK: BZCN)

BizAuction Inc. (BZCN) is a provider of commercial eBay liquidation services for excess inventory, overstock items, and returns for retailers, manufacturers and distributors. The Company sells from home goods, brand name clothes and electronics. The Company lists the merchandise through software which is integrated and compliant with eBay. Once an auction ends, payment is collected via PayPal or credit card. The Company is providing liquidation services to retailers in California, Arizona and Colorado, and is in the process of expanding into other states. continue